Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
EONR$0.40-0.02(-3.58%)EON Resources Inc. Provides FAQ Responses in Advance of Earnings Call[6:55:00 PM ET]PDS$99.96+1.16(+1.17%)Precision Drilling Announces 2026 Third Quarter Unaudited Financial Statements[6:42:54 PM ET]TAC$12.87+0.60(+4.89%)TransAlta Declares Dividends[6:40:57 PM ET]GTERU$10.57+0.19(+1.83%)Globa Terra Acquisition Corporation Reports Encouraging Investor Support Ahead of November 9 Extension Vote[6:30:00 PM ET]LU$8.40-0.08(-0.94%)Lufax Reports Third Quarter 2026 Financial Results Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China,...[6:30:00 PM ET]AMGN$451.95+7.32(+1.65%)AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND Amgen (NASDAQ: AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the fourth quarter of 2026. The dividend...[6:27:00 PM ET]GAMXF$0.05+0.01(+25.20%)Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options[6:25:00 PM ET]CBRE$121.65-1.23(-1.00%)CBRE Group, Inc. Announces Pricing of $500 Million Senior Notes due 2032 and $500 Million Senior Notes due 2037[6:21:00 PM ET]IEP$5.59-0.16(-2.78%)Icahn Enterprises L.P. Announces Q3 2026 Earnings Conference Call Icahn Enterprises L.P. (Nasdaq:IEP) announced today that it will discuss its third quarter 2026 results on a webcast on Tuesday, November 3, 2026 -...[6:18:00 PM ET]CHD$105.01-0.37(-0.35%)Church & Dwight Co., Inc. Declares 503rd Regular Quarterly Dividend[6:15:00 PM ET]PMT$7.26+0.20(+2.83%)KBRA Assigns Preliminary Ratings to PMT Loan Trust 2026-INV10 (PMTLT 2026-INV10)[6:13:00 PM ET]URGN$33.91-0.13(-0.38%)UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026[6:00:13 PM ET]RRR$49.58-0.68(-1.35%)NORTH FORK MONO CASINO IN MADERA, CA OPENS TODAY AT 3PM OCTOBER 27 North Fork Mono Casino officially opened its doors today at 3:00 PM, treating visitors to an unexpected early opening. The new casino resort is...[6:00:00 PM ET]NKTR$37.90+0.45(+1.20%)Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026, ...[6:00:00 PM ET]

EOLS · NASDAQ

Evolus, Inc.

$7.30 +0.13 (+1.74%)

Company overview

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Market cap
$482M
Employees
372
Headquarters
Newport Beach, CA
Website
evolus.com
CEO
David Moatazedi
Listed
February 8, 2018
P/E
-10.93
Dividend yield
0.00%

Company financials

Revenue
$302M
Gross profit
$198M
Operating income
-$28.9M
EBITDA
-$14M
Net income
-$43.4M
EPS
-$0.67
Total assets
$221M
Total debt
$165M
Gross margin
65.55%
Net margin
-14.39%
Earnings yield
-9.15%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No annual geographic segmentation.

Showing FY 2025

Price chart

4.956.087.218.359.48
EOLS 1D NASDAQ O7.06H7.19L6.90C7.17+0.16 (+2.28%)Vol430.11K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
EOLSEvolus, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS GlobeNewswire
EOLSEvolus, Inc. Legal Evolus, Inc. (EOLS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation ACCESS Newswire
EOLSEvolus, Inc. Legal Bronstein, Gewirtz & Grossman, LLC Encourages Evolus, Inc. (EOLS) Shareholders to Inquire about Securities Investigation ACCESS Newswire
EOLSEvolus, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS ACCESS Newswire
EOLSEvolus, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS PRNewsWire
EOLSEvolus, Inc. Legal Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Evolus, Inc. (EOLS) and Encourages Investors to Learn More About the Investigation ACCESS Newswire
EOLSEvolus, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS ACCESS Newswire
EOLSEvolus, Inc. Legal Bronstein, Gewirtz & Grossman, LLC Is Investigating Evolus, Inc. (EOLS) And Encourages Investors to Connect ACCESS Newswire
EOLSEvolus, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS ACCESS Newswire
EOLSEvolus, Inc. Legal Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Evolus, Inc. (EOLS) and Encourages Stockholders to Learn More About the Investigation ACCESS Newswire
EOLSEvolus, Inc. Legal Bronstein, Gewirtz & Grossman, LLC Encourages Evolus, Inc. (EOLS) Investors to Inquire about Securities Investigation ACCESS Newswire
EOLSEvolus, Inc. Press release Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program Business Wire
EOLSEvolus, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS ACCESS Newswire
EOLSEvolus, Inc. Legal EOLS Investors with $100,000 in Losses Have Opportunity to Join Evolus, Inc. Fraud Investigation with SBS Law Business Wire
EOLSEvolus, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS ACCESS Newswire
EOLSEvolus, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS GlobeNewsWire
EOLSEvolus, Inc. Stock news Evolus Warned Over Misbranding in Social Media Promo for Frown Lines Drug Benzinga
EOLSEvolus, Inc. Press release Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes Business Wire
EOLSEvolus, Inc. Stock news A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture GuruFocus
EOLSEvolus, Inc. Press release Telix Appoints David Gill as Chair GlobeNewswire
See more
FAQ

Questions about Evolus, Inc.

What does Evolus, Inc. do?
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
What is EOLS's market cap?
Evolus, Inc. (EOLS) is a listed stock with a live quote. The latest market cap on this page is $482M.
Where is Evolus, Inc. headquartered?
Evolus, Inc. is headquartered in Newport Beach, CA.
How do I get EOLS news from the API?
Call GET /v1/news?tickers=EOLS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does EOLS news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for EOLS, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the EOLS price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs